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Abstract
Background: Although pulsed electromagnetic field (PEMF) stimulation may be clinically beneficial during fracture
healing and for a wide range of bone disorders, there is still debate on its working mechanism. Mesenchymal stem
cells are likely mediators facilitating the observed clinical effects of PEMF. Here, we performed in vitro experiments
to investigate the effect of PEMF stimulation on human bone marrow-derived stromal cell (BMSC) metabolism and,
specifically, whether PEMF can stimulate their osteogenic differentiation.
Methods: BMSCs derived from four different donors were cultured in osteogenic medium, with the PEMF treated
group being continuously exposed to a 15 Hz, 1 Gauss EM field, consisting of 5-millisecond bursts with 5-
microsecond pulses. On culture day 1, 5, 9, and 14, cells were collected for biochemical analysis (DNA amount,
alkaline phosphatase activity, calcium deposition), expression of various osteoblast-relevant genes and activation of
extracellular signal-regulated kinase (ERK) signaling. Differences between treated and control groups were analyzed
using the Wilcoxon signed rank test, and considered significant when p < 0.05.
Results: Biochemical analysis revealed significant, differentiation stage-dependent, PEMF-induced differences: PEMF
increased mineralization at day 9 and 14, without altering alkaline phosphatase activity. Cell proliferation, as
measured by DNA amounts, was not affected by PEMF until day 14. Here, DNA content stagnated in PEMF treated
group, resulting in less DNA compared to control.
Quantitative RT-PCR revealed that during early culture, up to day 9, PEMF treatment increased mRNA levels of
bone morphogenetic protein 2, transforming growth factor-beta 1, osteoprotegerin, matrix metalloproteinase-1 and
-3, osteocalcin, and bone sialoprotein. In contrast, receptor activator of NF-B ligand expression was primarily
stimulated on day 14. ERK1/2 phosphorylation was not affected by PEMF stimulation.
Conclusions: PEMF exposure of differentiating human BMSCs enhanced mineralization and seemed to induce
differentiation at the expense of proliferation. The osteogenic stimulus of PEMF was confirmed by the up-
regulation of several osteogenic marker genes in the PEMF treated group, which preceded the deposition of
mineral itself. These findings indicate that PEMF can directly stimulate osteoprogenitor cells towards osteogenic
differentiation. This supports the theory that PEMF treatment may recruit these cells to facilitate an osteogenic
response in vivo.
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Background
Pulsed electromagnetic field (PEMF) stimulation may be
clinically beneficial in the treatment of fracture healing,
especially in non-unions [1-3]. There are indications that
PEMF might also be effective in the treatment of osteo-
porosis [4-6]. While there is a relatively frequent clinical
use of electromagnetic stimulation, current evidence from
randomized trials is insufficient to conclude a benefit of
this treatment modality [7]. Although more knowledge on
PEMF-induced effects is becoming available, the underly-
ing cellular mechanisms remain poorly understood.
Likely candidates that might facilitate a stimulatory
effect of PEMF in fracture healing are the osteoblasts, or
their precursors, the mesenchymal stem cells (MSCs).
Aaron et al. suggested that PEMF-enhanced differentiation
of mesenchymal stem cells is most likely responsible for
the increase in extracellular matrix synthesis and bone
maturation [8]. Recent studies indicate that progenitor
cells may migrate into bone fracture sites and initiate
osteogenic lineage commitment [9]. However, little is
known about direct PEMF-induced effects on osteopro-
genitor cells as the most likely cell population contributing
to the osteogenic response [10-12]. Only recently, Tsai et
al. demonstrated a modulating role of PEMF stimulation
in MSC osteogenesis [11]. Furthermore, Sun et al. postu-
lated that PEMF exposure could enhance bone marrow
mesenchymal stem cells proliferation [12].
To induce a biological response, translation of the
electromagnetic signal into a biochemical signal is obli-
gatory. Various, albeit somewhat conflicting, effects of
PEMF on transcriptional level, cell proliferation and dif-
ferentiation have been reported in osteoblasts [13-19].
Multiple studies report positive effects of PEMF on
mineralization in osteoblast-like cell cultures [20-22].
This supports findings of in vivo studies which show an
increase of mineral apposition rate after PEMF treat-
ment [23,24]. Besides PEMF-induced effects on cellular
differentiation, there is increasing evidence suggesting
that effects of electromagnetic stimulation are also
dependent on cellular maturation stage [8,20,25,26].
Aaron et al. report a temporal stimulation in the
mesenchymal stage of endochondral bone development,
essential for accelerated bone formation. Additionally,
Diniz et al showed that PEMF had a stimulatory effect
on the osteoblasts in the early stages of culture, which
increased bone tissue-like formation, but decreased bone
tissue-like formation in the mineralization stage.
Although many factors are known to be involved in
bone growth and repair, the transforming growth factor
beta (TGF-b1) family of proteins, including bone mor-
phogenetic proteins (BMPs), are of particular interest
due to their well-recognized osteogenic potential [27].
Exogenous BMPs are currently being clinically used to
treat non-union fractures [28,29]. PEMF-induced up-
regulation of BMP-2 and -4 mRNA has been demon-
strated in rat osteoblasts [30]. Additionally, PEMF-
enhanced effects of BMP-2 treatment on osteoblastic
cell differentiation has been shown in both rat osteo-
blastic cells and human MSCs [31,32]. Another impor-
tant bone remodeling system is based on the interaction
between osteoblast and osteoclast, regulated by osteo-
protegerin (OPG) and receptor activator of NF-B
ligand (RANKL). In particular, the OPG/RANKL ratio is
considered to be the dominant regulator, while an
increased ratio will result in decreased osteoclastogen-
esis and thus have an osteoprotective effect [33]. Chang
et al. showed PEMF-induced up-regulation of OPG
while RANKL mRNA expression was down-regulated,
resulting in an increased OPG/RANKL ratio [14].
Matrix metalloproteinases (MMPs) are enzymes
responsible for the proteolytic degradation of extracellu-
lar matrix components such as collagen that also play a
crucial role in bone remodeling. Previous studies have
shown that expression of MMPs in osteoblasts can be
induced by a variety of extracellular stimuli like e.g.
mechanical loading [34-36]. However, the effect of PEMF
on MMP expression in MSCs has not yet been studied.
While the majority of reported PEMF-induced effects
were studied in osteoblasts, findings in literature indi-
cate that MSCs could be a more relevant cell source in
vivo. We hypothesize that PEMF directly stimulates
osteoprogenitors towards osteogenic differentiation. The
current study investigates the effects of PEMF on
human bone marrow-derived stromal cells (BMSCs)
during subsequent stages of osteogenic differentiation.
DNA amounts, differentiation, and mineralization were
monitored to assess maturation stage. To address which
mediators play a role in PEMF exerted effects in
BMSCs, mRNA expression levels of osteoblast-relevant
genes were tested during the differentiation process. As
PEMF induced effects on proliferation may be cell type
dependent, DNA amounts were monitored in both
BMSCs and already committed human fetal pre-osteo-
blasts (SV-HFOs). The extracellular signal-regulated
kinase-1/2 (ERK) signaling pathway is crucial for osteo-
blast function and differentiation [37-39]. As ERK sig-
naling is known to play an important role in
mechanotransduction [36,40,41], its possible involve-
ment in PEMF-mediated effects was assessed.
Methods
Cell culture
Human bone marrow stromal cells (BMSCs) were iso-
lated from bone marrow aspirates obtained during total
hip revision surgery after approval by the local ethical
committee (MEC2004-322). Bone marrow aspirates were
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taken from the greater trochanter. Heparinized aspirates
were seeded at a density of 30 to 90 × 106 nucleated
cells per T175 flask. After 24 h, non-adherent cells and
cell debris were washed out. hBMSCs were further
expanded in low-glucose Dulbecco’s modified Eagle
medium (DMEM) (Gibco, Paisly, UK) with 10% fetal
calf serum (FCS) from a pre-selected batch to maintain
the multipotential capacities of the cells, 50 μg/mL of
gentamicin, and 1.5 μg/mL of Fungizone (all Invitrogen,
Carlsbad, CA) and 0.1 mM of L-ascorbic acid 2-phos-
phate and 1 ng/mL of fibroblast growth factor (Instru-
chemie B.V., Delfzijl, the Netherlands). Cells were
cultured at 37°C under humidified conditions and 5%
carbon dioxide (CO2). Medium was changed twice a
week. When cultures neared confluence, they were tryp-
sinized using 0.05% trypsin and replated at a density of
2000 cells/cm2. Cells from the second to the fourth pas-
sage were used for experimental purpose [42]. After
expansion, cells were seeded onto six-well plates at an
initial density of approximately 1 × 105 cells per well,
and cultured up to 14 days in osteogenic medium:
DMEM containing 10% FCS, 0.1 mM ascorbic acid,
1 μM dexamethasone (Sigma, St. Louis, MO), and
10 mM b-glycerophosphate (Sigma). The BMSCs from
four different donors were analyzed after 1, 5, 9, or
14 days of culture in osteogenic media. All cultures
were fully mineralized after 14 days.
SV40-immortalized human fetal pre-osteoblasts (SV-
HFO) were seeded similarly to the BMSCs and cultured
in aMEM medium without phenol red (Gibco) and 2%
FCS [43,44]. To induce osteoblastic differentiation,
1 μM dexamethasone and 10 mM b-glycerophosphate
was added to the medium. Cells were induced towards
osteoblastic differentiation as described earlier and har-
vested after 7, 14, or 21 days after which they were fully
mineralized. To exclude a possible influence of serum
on PEMF-induced effects, additional experiments with
varying percentage FCS (2 or 10%) were conducted with
emphasis on DNA amount.
Pulsed electromagnetic field
Pulsed electromagnetic fields (PEMF) were generated by
a commercially available bone-healing device (Ortho-
pulse® II, IMD, currently distributed by OSSATEC®,
Uden, The Netherlands). The coils of the device were
supported by an acrylic frame in which six-well plates
were placed. Treated cell cultures were continuously
exposed to a 15 Hz, 1 Gauss EM field, consisting of
5-millisecond bursts with 5-microsecond pulses.
Analysis
DNA, alkaline phosphatase activity and mineralization -
For characterization, DNA amount, alkaline phophatase
(ALP) activity and calcium deposition as a measure for
mineralization were determined. Cell lysates in 0.1%
PBS-Triton X-100 were treated with heparin and RNase
A (50 mg/ml in PBS) for 30 minutes at 37°C. DNA con-
tent was measured according to the ethidium bromide
method by Karsten and Wollenberger [45]. Calcium
deposition into the extracellular matrix was determined
after overnight extraction with HCl, using the Sigma cal-
cium assay according to manufacturer’s description.
Alkaline phosphatase activity was determined by the col-
orimetric method of Lowry et al.[46]. Results were
adjusted for DNA content of the corresponding cell
lysates.
Western blotting
On day 14, SV-HFOs or BMSCs were lysed in buffer
(200 μl/well) containing 25 mM HEPES, 1% Triton X-
100, 1% deoxycholate, 0.1% SDS, 0.5 M NaCl, 5 mM
EDTA, 50 mM NaF, 1 mM PMSF, 1 mM Na3VO4, 10
μg/ml leupeptin, and 2 mM b-glycerophosphate, and
harvested with a cell scraper. After centrifugation at
11000× g for 15 minutes, supernatant was collected and
stored at -80°C until further use. Protein levels were
determined using BCA protein assay kit (Pierce, Rock-
ford, IL). Cell lysate (10 μg protein/lane) was separated
by SDS-PAGE and transferred to Hybond+ nitrocellu-
lose membranes (Amersham Pharmacia Biotech, Piscat-
away, NJ). After overnight blocking in TBS + 0.1%
Tween 20 containing 5% (w/v) bovine serum albumine,
membranes were incubated with monoclonal anti-ERK1/
2-P antibodies (1:2000, Cell Signaling, Beverly, MA) for
3 h at room temperature and detected using horseradish
peroxidase coupled secondary antibodies and the ECL
detection system (Amersham Pharmacia Biotech). After
exposure to Kodak HR film, immunoreactive bands at
42 kD and 44 kD were quantified using Quantity One
(Bio-Rad) software. Finally, all blots were stripped and
blocked again for incubation with monoclonal antibo-
dies against ERK1/2 (1:2000, Cell Signaling, Beverly,
MA). Total ERK1/2 levels were used as loading controls.
Quantification of gene expression
BMSCs were collected in 500 μl RNA-Bee™(TEL-TEST,
Friendswood, TX, USA) per well. RNA was purified,
quantified and reverse transcribed as described earlier
[36]. Real-time PCR conditions and normalization to
GAPDH, which was stably expressed throughout the
experiments, were adopted from Das et al. [47,48]. Taq-
Man® hydrolysis probe assays are reported by Mandl et
al. [49], while remaining primer and probe nucleotide
sequences (Table 1) were designed using PrimerEx-
press2.0. All Taqman assays were performed in tripli-
cates in 96-well optical plates using qPCR™ Core Kit
(Eurogentec, Maastricht, The Netherlands) and similar
amplification efficiencies between assays were verified by
cDNA serial dilutions (data not shown). Specificity of
listed oligonucleotides was checked by BLASTN® (Basic
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Local Alignment Search Tool) against the human RefSeq
RNA database at NCBI and verified by standard agarose
gel electrophoresis.
Statistics
Experiments were performed using BMSCs from four
different donors. Within each donor, conditions were
tested in triplicate (n = 3). Data are presented as means
from four donors for each condition ± standard devia-
tion. Statistical analysis was performed on all triplicates
from the four donors. To take donor variability into
consideration, experimental groups were analyzed using
the Wilcoxon signed rank test, and considered signifi-
cant when p < 0.05. For SV-HFOs, experiments were
performed in triplicate (n = 3). Differences were ana-
lyzed using the Mann-Whitney U test and considered
significant when P < 0.05.
Results
Cultured in osteogenic medium, human bone marrow
stromal stem cells (BMSCs) and fetal pre-osteoblasts
(SV-HFOs) showed a gradual increase in DNA content
over time (figure 1). Both cell types were cultured up to
full mineralization. In BMSCs, PEMF treatment did not
significantly alter DNA amount until day 14, when DNA
contents per well further increased in the control group
but not in the PEMF-treated group (figure 1A). In SV-
HFOs, no effect of PEMF on DNA content was observed
at any differentiation stage (figure 1B), regardless of the
percentage of serum used (data not shown). In general,
alkaline phosphatase (ALP) activity increased around
day 5, both in the PEMF treated cells and controls.
However, the time point at which peak activity was
reached, varied between BMSCs from different donors
Table 1 List of genes and primer and probe nucleotide sequences
Gene Primer# Reference Primer (5′-3′)
OC F NM_199173.3 GAAGCCCAGCGGTGC
R CACTACCTCGCTGCCCTCC
FAM TGGACACAAAGGCTGCACCTTTGCT
OPG F NM_002546.3 GCAGCGGCACATTGGAC
R CCCGGTAAGCTTTCCATCAA
FAM TGCTAACCTCACCTTCGAGCAGCTTCGTA
RANKL F NM_003701.2 CGTTGGATCACAGCACATCAG
R NM_033012.2 GCTCCTCTTGGCCAGATCTAAC
FAM CAGAGAAAGCGATGGTGGATGGCTCAT
BMP2 F NM_001200.2 AACACTGTGCGCAGCTTCC
R CTCCGGGTTGTTTTCCCAC
FAM CCATGAAGAATCTTTGGAAGAACTACCAGAAACTG
TGF-b1 F NM_000660.3 CGAGCCTGAGGCCGACTAC
R AGATTTCGTTGTGGGTTTCCA
FAM -
SPP1 F NM_001040060.1 CTCAGGCCAGTTGCAGCC
R NM_001040058.1 CAAAAGCAAATCACTGCAATTCTC
FAM NM_000582.2 AAACGCCGACCAAGGAAAACTCACTACC
SPARC F NM_003118.2 ATCTTCCCTGTACACTGGCAGTTC
R CTCGGTGTGGGAGAGGTACC
FAM CAGCTGGACCAGCACCCCATTGAC
IBSP F NM_004967.2 TGCCTTGAGCCTGCTTCC
R GCAAAATTAAAGCAGTCTTCATTTTG
FAM CTCCAGGACTGCCAGAGGAAGCAATCA
MMP-1 F NM_002421 CTCAATTTCACTTCTGTTTTCTG
R CATCTCTGTCGGCAAATTCGT
FAM CACAACTGCCAAATGGGCTTGAAGC
MMP-3 F NM_002422 TTTTGGCCATCTCTTCCTTCA
R TGTGGATGCCTCTTGGGTATC
FAM AACTTCATATGCGGCATCCACGCC
# Primer = Forward (F), Reverse (R), FAM-labeled TaqMan® probe (FAM). All assays are TaqMan® assays except for TGF- b1 (SYBRGreen assay).
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causing high standard deviation at day 5. At day 14, a
further increase in ALP per DNA was observed. In
general, ALP activity was not significantly affected by
PEMF treatment (figure 2A). PEMF treatment did not
affect the timing of matrix mineralization, starting
around day 9 in both the control and PEMF treated
groups. At day 9 and 14, mineralization (measured as
amount of calcium normalized to DNA) was stronger
induced in the PEMF treated group (figure 2B).
Expression levels of osteoblast-relevant genes in
human BMSCs ranged from highly abundant collagen I
(COL I, CT≈ 17) to weakly expressed receptor activator
of NF-B ligand (RANKL, CT≈ 33). In general, highest
expression levels were observed just before and around
the onset of mineralization (day 5 and 9). The reference
gene GAPDH remained stably expressed at all tested
days throughout the experiment. Bone morphogenetic
protein 2 (BMP-2) was most responsive to PEMF, with a
maximum increase in expression of 3.5-fold over control
on day 9 of culture (figure 3A). Expression of transform-
ing growth factor-beta (TGF-b1) was 2.5-fold up-regu-
lated upon PEMF treatment at the same day (figure 3B).
Interestingly, neither gene was affected by PEMF at the
later stages of mineralization (day 14). Matrix metallo-
proteinase (MMP) -1 and -3 expression levels were both
up-regulated by PEMF (figure 3C + D): MMP-1 was
found to be constantly up-regulated until day 9, reach-
ing a 2.8-fold expression, while MMP-3 was up-regu-
lated until day 5 (2.1-fold). Again, no significant effect
of PEMF was observed on day 14 for both MMPs.
Other tested genes that were up-regulated by PEMF
were osteoprotegerin (OPG: 1.7-fold; figure 3E), bone
sialoprotein (IBSP: 2-fold; figure 4G), and osteocalcin
(OC: 2-fold; figure 4H). However, on day 14 the stimula-
tory effect of PEMF was no longer apparent for the
above-mentioned genes. In contrast, RANKL expression,
which was insensitive to PEMF treatment earlier in
BMSC culture (day 5 and 9), was stimulated on day 14
(figure 3D). The OPG/RANKL ratio was calculated to
indicate possible effects on osteoclastogenesis. Until day
9, the ratio increased due to PEMF. At day 14, however,
the ratio was reversed again (figure 5). Expression of
collagen type I (COL1; figure 4I), osteopontin (SPP1; fig-
ure 4J) and osteonectin (SPARC; figure 4K) was not sig-
nificantly regulated by PEMF stimulation, although a
stimulatory trend was observed for collagen I from day
1 to day 9 (p-values of 0.086 on day 1 and 0.074 on day
5).
To address a potential ERK activation upon PEMF
treatment, SV-HFOs and BMSCs were exposed to 15
minutes of PEMF on day 14. During this stage of miner-
alization, PEMF-induced signaling seems to be ERK-
independent as no significant differences in phosphory-
lation could be detected. Total ERK levels were similar
between the PEMF treated and control groups, indicat-
ing equal loading (figure 6).
Figure 1 Effect of PEMF stimulation on DNA amounts in two
different cell types. A) human bone marrow derived stromal cells,
obtained from 4 different donors (n = 3 per donor), B) human fetal
pre-osteoblasts (n = 3). Cells were cultured in osteogenic medium
to full mineralization. Significant differences due to PEMF are
marked * (p < 0.05, Wilcoxon signed rank test).
Figure 2 Effect of PEMF stimulation on osteogenic
differentiation of human BMSCs. Figure shows alkaline
phosphatase activity (A) and calcium deposition in the extracellular
matrix (B) of these cells. Cells were obtained from 4 differenent
donors (n = 3 per donor). Significant differences due to PEMF are
marked * (p < 0.05, Wilcoxon signed rank test).
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Discussion
We found that PEMF stimulation of osteogenic differen-
tiating BMSCs enhanced mineralization after 14 days of
PEMF exposure, compared to the control. The ability of
PEMF to promote mineralization has been described in
osteoblasts [31], but not yet been demonstrated in
BMSCs. Tsai et al. recently showed a modulating role of
PEMF in similar cells [11]. In contrast to our findings,
no effect of PEMF on mineralization was observed.
However, by only using a histochemical staining on day
14 and 28, subtle changes in mineralization may have
been missed in their setup.
Figure 3 Effect of PEMF on osteoblast-relavant genes in human BMSCs. Gene expression ratios of selected genes plotted as expression in
PEMF-treated condition relative to non-treated control. Targeted genes are A) bone morphogenetic protein 2 (BMP-2); B) transforming growth
factor beta 1 (TGF-b1); C) osteoprotegrin (OPG); D) receptor activator of NF-kappa-B ligand (RANKL); E) matrix metalloproteinase 1 (MMP-1); F)
matrix metalloproteinase 3 (MMP-3). Significant differences due to PEMF are marked * (p < 0.05), n = 4.
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Interestingly, DNA amounts did not further increase in
the PEMF treated BMSC culture after day 9, while they
did in the control group. PEMF seemed to induce differen-
tiation at the expense of proliferation - a generally
accepted principle that has been demonstrated using
osteoblasts, as well as human mesenchymal stem cells
[11,14,20]. The osteogenic stimulus of PEMF was further
confirmed by the up-regulation of several osteogenic mar-
ker genes (e.g. BMP-2, OC, IBSP) in the PEMF treated
group, which preceded the deposition of mineral (Ca2+)
itself. These findings strongly suggest that PEMF stimula-
tion enhanced osteogenic differentiation in BMSCs.
PEMF exposure did not affect DNA content in BMSCs
until day 14. Here, the increase in DNA content halted
Figure 4 Effect of PEMF on osteoblast-relavant genes in human BMSCs. Gene expression ratios of selected genes plotted as expression in
PEMF-treated condition relative to non-treated control. Targeted genes are G) collagen 1 (COL1); H) osteocalcin (OC); I) bone sialoprotein 1
(IBSP); J) osteonectin (SPARC); K) osteopontin (SPP1). Significant differences due to PEMF are marked * (p < 0.05), n = 4.
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in the PEMF treated BMSC group, parallel with the
onset of mineralization. This could well be the result of
inhibition of proliferation, a process required to proceed
through the maturation process [50]. Another explana-
tion for this finding is PEMF-induced apoptosis,
although a previous study by Nikolova et al. points out
that, while PEMF exposure transiently may affect the
transcript level of genes related to apoptosis and cell
cycle control [51], no detectable changes of cell physiol-
ogy were found.
Data on proliferative effects of PEMF described in lit-
erature in osteoblasts vary considerably: the maximum
effect of PEMF exposure on cell proliferation appears to
depend on the percentage of FCS in the medium [52],
cell density [53], cell type [54], differentiation stage and
characteristics of PEMF [55]. In order to verify our find-
ings of PEMF on cell number in BMSCs, we examined
PEMF effects on DNA amount in various human cell
types, including SV-HFOs (Figure 1B) and human
umbilical vein endothelial cells (not shown). No signifi-
cant effect on DNA content was found, despite low
initial cell density or the presence of 10% serum, as
described by others [13,15,52,54]. Additionally, the vari-
ety in characteristics of PEMF devices used in separate
studies may contribute to different findings between
research groups. Matsunaga et al. have shown PEMF-
induced osteogenesis to be dependent on the intensity
and pulse duration of the stimulation [55].
In our culture model, the onset of mineralization on
day 9 seemed to be an important hallmark with respect
to regulation of gene expression by PEMF. Most genes
were up-regulated in the period preceding and during
the onset of mineralization. TGF-b1 expression, which
was induced by PEMF up to day 9, is also elevated in
osteoblasts subjected to mechanical strain [56], and an
important role of this cytokine in fracture repair has
been suggested [57]. Expression of BMP-2 was also gra-
dually stimulated upon PEMF exposure up to 3.5 fold
until the onset of mineralization. BMPs have been used
successfully in the clinical setting to help treat non-
union fractures, often in combination with bone grafts
[58], and one might that PEMF’s reported positive
effects may be secondary to an endogenous stimulation
of osteoinductive cytokines of the TGF-beta superfamily
(e.g., BMP-2, -4, -7) in vivo. In vitro studies have
demonstrated osteogenic differentiation of rat primary
osteoblastic cells and human MSCs after treatment with
BMP-2, the latter being further enhanced upon PEMF
stimulation [10,31]. Several BMPs have been shown to
dominantly induce osteogenic differentiation of MSCs
independent of other known stimuli [59]. Moreover,
BMP-2 strongly induces osteogenic transdifferentiation
of other progenitors, like myogenic cells [60]. Increased
BMP-2 mRNA levels after PEMF treatment have been
shown in chick embryonic calvaria and rat osteoblasts,
indicating that PEMF indeed mediates endogenous sti-
mulation of BMPs [30,61,62]. Additionally, Wang et al.
found increased BMP-2 protein production after stimu-
lation with electric fields [62].
We demonstrated PEMF-induced up-regulation of
MMPs in human BMSCs during osteoblastic differentia-
tion, which has not earlier been evaluated in relation to
PEMF treatment. Again, these effects were observed until
day 9 of culture. The up-regulation of MMPs may result
in faster remodeling of collagenous matrix, and is for
example observed during increased bone turnover. Typi-
cally, both MMP-1 and -3 and mineralization were
induced by mechanical loading in vitro as well [36].
PEMF-induced up-regulation of MMP expression might
be indicative of increased matrix remodeling and play a
crucial role in the beneficial clinical results of PEMF in
treatment of non-unions. Not surprisingly, expression of
extracellular matrix marker proteins, like osteocalcin and
Figure 5 Effect of PEMF on OPG/RANKL expression ratio in
human BMSCs. Gene expression ratios of OPG/RANKL plotted as
expression in PEMF-treated condition relative to non-treated control.
Significant differences due to PEMF are marked * (p < 0.05), n = 4.
Figure 6 Western blot showing activated, phosphorylated ERK
(ERK1/2-P) next to total ERK (ERK1/2) specific signals as
loading control. Human fetal pre-osteoblasts (SV-HFO) and bone
marrow stromal cells (BMSC) were cultured up to day 14 prior to
PEMF treatment. PEMF exposure of 15 minutes was compared with
control (0 minutes of PEMF).
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bone sialoprotein, was found to be up-regulated after
PEMF exposure until day 9, too. Although not signifi-
cantly, collagen type I expression was steadily induced in
the early stages of differentiation (p-values of 0.086 on day
1 and 0.074 on day 5), potentially facilitating extracellular
matrix synthesis. Heermeier et al. also found enhancement
of collagen type I mRNA expression after stimulation with
electromagnetic field in human osteoblastic cells, which
was induced by TGF-b treatment as well [63].
Our data suggest that the strongest effect of PEMF on
BMSCs and stimulation of mineralization is exerted in
the period prior to mineralization. This notion is sup-
ported by data from Aaron and Ciombor, who investi-
gated the effects of PEMF in a model of endochondral
bone formation, and reported that PEMF stimulation in
the early stages of mesenchymal maturation was more
effective in increasing ossicles’ development and minera-
lization than stimulation in the later stages [8]. The
importance of the period prior to mineralization for the
eventual extent of mineralization is supported by recent
data by Eijken et al., demonstrating control of minerali-
zation by early osteoblastic effects [64]. Interestingly,
Tsai et al also observed down-regulation of osteogenic
marker genes in PEMF exposed MSCs, after initial up-
regulation [11]. Although the underlying mechanism is
not clear, this implicates that the effect of PEMF on
gene expression is importantly dependent on differentia-
tion stage of the cells. Additionally, we found an
increase in OPG mRNA expression after PEMF on day
9, while that of RANKL was not significantly altered.
This resulted in a potentially osteoprotective increase in
the OPG/RANKL ratio, which is in agreement with data
from murine osteoblasts [14]. However, the expression
pattern reversed on day 14.
Alkaline phosphatase increased around day 5. While
ALP is an important marker for osteoblast differentia-
tion, we did not observe a significant PEMF induced
increase. Tsai et al. demonstrated a PEMF induced
increase in ALP activity only on day 7, but not on day 3
and 10 [11]. As we experienced variations of the time
point at which peak activity was reached between
BMSCs, it is possible that we missed the PEMF induced
stimulation of ALP activity.
Nie et al. reported a modulation of ERK activation by
PEMF in fibroblasts [18]. ERK signaling is crucial for
osteoblast function and differentiation, and has been
shown to be activated upon mechanical stimuli in osteo-
blasts and MSCs. Interestingly, PEMF did not increase
ERK phosphorylation in our experimental setup,
although culture conditions were identical to those used
previously to demonstrate activation of ERK after stretch
[65]. This indicates that PEMF and mechanical stimuli
may act via different ways of mechanotransduction in
differentiating osteoblasts as compared to fibroblasts.
Conclusions
PEMF exposure of differentiating human BMSCs
resulted in early up-regulation of several osteoblast-
related genes and enhanced mineralization. These find-
ings indicate that PEMF can directly stimulate mesench-
ymal stem cells and promote osteogenesis.
Differentiation stage, and in particular the onset of
mineralization, appeared to be an important hallmark
with respect to gene regulation by PEMF. Stimulatory
effects were predominantly observed in the pre-minera-
lization period. These findings support the theory that
in vivo PEMF treatment may recruit human bone mar-
row stromal cells to the osteogenic lineage and use
these cells as likely cell pool to facilitate an osteogenic
response.
Acknowledgements
Aided by a grant from the Association Internationale pour l’Osteosythèse
Dynamique” (AIOD).
Author details
1Department of Orthopaedics, Erasmus University Medical Center, P.O. Box
2040, 3000 CA Rotterdam, The Netherlands. 2Department of Internal
Medicine, Erasmus University Medical Center, P.O. Box 2040, 3000 CA
Rotterdam, The Netherlands. 3Department of Surgery, Albert Schweitzer
Hospital, P.O. Box 444, 3300 AK Dordrecht, The Netherlands.
Authors’ contributions
JHJ conceived of the study, designed the study, carried out the experiments,
performed statistical analysis and drafted the manuscript. OPJ participated in
the design of the study and carried out the experiments. BJP conceived of
the study and helped to draft the manuscript. JAV participated in its design
and coordination, and helped to draft the manuscript. JPL participated in
the design and coordination, and helped to draft the manuscript. HW
conceived of the study, participated in its design and coordination, and
helped to draft the manuscript. HJ participated in the study design,
developed primer-probe sets, participated in coordination and helped to
draft the manuscript.
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 6 December 2009 Accepted: 23 August 2010
Published: 23 August 2010
References
1. Heckman JD, Ingram AJ, Loyd RD, Luck JV Jr, Mayer PW: Nonunion
treatment with pulsed electromagnetic fields. Clin Orthop 1981, 58-66.
2. Bassett CA, Pawluk RJ, Pilla AA: Acceleration of fracture repair by
electromagnetic fields. A surgically noninvasive method. Ann N Y Acad
Sci 1974, 238:242-262.
3. Griffin XL, Warner F, Costa M: The role of electromagnetic stimulation in
the management of established non-union of long bone fractures: what
is the evidence? Injury 2008, 39:419-429.
4. Skerry TM, Pead MJ, Lanyon LE: Modulation of bone loss during disuse by
pulsed electromagnetic fields. J Orthop Res 1991, 9:600-608.
5. Rubin CT, Donahue HJ, Rubin JE, McLeod KJ: Optimization of electric field
parameters for the control of bone remodeling: exploitation of an
indigenous mechanism for the prevention of osteopenia. J Bone Miner
Res 1993, 8(Suppl 2):S573-581.
6. Tabrah F, Hoffmeier M, Gilbert F Jr, Batkin S, Bassett CA: Bone density
changes in osteoporosis-prone women exposed to pulsed
electromagnetic fields (PEMFs). J Bone Miner Res 1990, 5:437-442.
Jansen et al. BMC Musculoskeletal Disorders 2010, 11:188
http://www.biomedcentral.com/1471-2474/11/188
Page 9 of 11
7. Mollon B, da Silva V, Busse JW, Einhorn TA, Bhandari M: Electrical
stimulation for long-bone fracture-healing: a meta-analysis of
randomized controlled trials. J Bone Joint Surg Am 2008, 90:2322-2330.
8. Aaron RK, Ciombor DM: Acceleration of experimental endochondral
ossification by biophysical stimulation of the progenitor cell pool. J
Orthop Res 1996, 14:582-589.
9. Kitaori T, Ito H, Schwarz EM, Tsutsumi R, Yoshitomi H, Oishi S, Nakano M,
Fujii N, Nagasawa T, Nakamura T: Stromal cell-derived factor 1/CXCR4
signaling is critical for the recruitment of mesenchymal stem cells to the
fracture site during skeletal repair in a mouse model. Arthritis Rheum
2009, 60:813-823.
10. Schwartz Z, Simon BJ, Duran MA, Barabino G, Chaudhri R, Boyan BD: Pulsed
electromagnetic fields enhance BMP-2 dependent osteoblastic
differentiation of human mesenchymal stem cells. J Orthop Res 2008,
26:1250-1255.
11. Tsai MT, Li WJ, Tuan RS, Chang WH: Modulation of osteogenesis in human
mesenchymal stem cells by specific pulsed electromagnetic field
stimulation. J Orthop Res 2009, 27:1169-1174.
12. Sun LY, Hsieh DK, Yu TC, Chiu HT, Lu SF, Luo GH, Kuo TK, Lee OK,
Chiou TW: Effect of pulsed electromagnetic field on the proliferation and
differentiation potential of human bone marrow mesenchymal stem
cells. Bioelectromagnetics 2009, 30:251-260.
13. Brighton CT, Wang W, Seldes R, Zhang G, Pollack SR: Signal transduction in
electrically stimulated bone cells. J Bone Joint Surg Am 2001, 83-
A:1514-1523.
14. Chang WH, Chen LT, Sun JS, Lin FH: Effect of pulse-burst electromagnetic
field stimulation on osteoblast cell activities. Bioelectromagnetics 2004,
25:457-465.
15. De Mattei M, Caruso A, Traina GC, Pezzetti F, Baroni T, Sollazzo V:
Correlation between pulsed electromagnetic fields exposure time and
cell proliferation increase in human osteosarcoma cell lines and human
normal osteoblast cells in vitro. Bioelectromagnetics 1999, 20:177-182.
16. Diniz P, Soejima K, Ito G: Nitric oxide mediates the effects of pulsed
electromagnetic field stimulation on the osteoblast proliferation and
differentiation. Nitric Oxide 2002, 7:18-23.
17. Luben RA, Cain CD, Chen MC, Rosen DM, Adey WR: Effects of
electromagnetic stimuli on bone and bone cells in vitro: inhibition of
responses to parathyroid hormone by low-energy low-frequency fields.
Proc Natl Acad Sci USA 1982, 79:4180-4184.
18. Nie K, Henderson A: MAP kinase activation in cells exposed to a 60 Hz
electromagnetic field. J Cell Biochem 2003, 90:1197-1206.
19. Fitzsimmons RJ, Ryaby JT, Mohan S, Magee FP, Baylink DJ: Combined
magnetic fields increase insulin-like growth factor-II in TE-85 human
osteosarcoma bone cell cultures. Endocrinology 1995, 136:3100-3106.
20. Diniz P, Shomura K, Soejima K, Ito G: Effects of pulsed electromagnetic
field (PEMF) stimulation on bone tissue like formation are dependent on
the maturation stages of the osteoblasts. Bioelectromagnetics 2002,
23:398-405.
21. Martino CF, Belchenko D, Ferguson V, Nielsen-Preiss S, Qi HJ: The effects of
pulsed electromagnetic fields on the cellular activity of SaOS-2 cells.
Bioelectromagnetics 2008, 29(2):125-132.
22. Wiesmann H, Hartig M, Stratmann U, Meyer U, Joos U: Electrical
stimulation influences mineral formation of osteoblast-like cells in vitro.
Biochim Biophys Acta 2001, 1538:28-37.
23. Taylor KF, Inoue N, Rafiee B, Tis JE, McHale KA, Chao EY: Effect of pulsed
electromagnetic fields on maturation of regenerate bone in a rabbit
limb lengthening model. J Orthop Res 2006, 24:2-10.
24. Inoue N, Ohnishi I, Chen D, Deitz LW, Schwardt JD, Chao EY: Effect of
pulsed electromagnetic fields (PEMF) on late-phase osteotomy gap
healing in a canine tibial model. J Orthop Res 2002, 20:1106-1114.
25. Grace KL, Revell WJ, Brookes M: The effects of pulsed electromagnetism
on fresh fracture healing: osteochondral repair in the rat femoral
groove. Orthopedics 1998, 21:297-302.
26. Norton LA: Effects of a pulsed electromagnetic field on a mixed
chondroblastic tissue culture. Clin Orthop Relat Res 1982, 280-290.
27. Kingsley D: Bone morphogenetic proteins in the formation and repair of
cartilage, bone and joints. In Skeletal growth and development: clinical
issues and basic science advances. Edited by: Buckwalter J, Ehrlich M, Sandell
L, Trippel S. Rosemont, IL: American Academy of Orthopaedic Surgeons;
1998:87-98.
28. Obert L, Deschaseaux F, Garbuio P: Critical analysis and efficacy of BMPs
in long bones non-union. Injury 2005, 36(Suppl 3):S38-42.
29. Kanakaris NK, Paliobeis C, Nlanidakis N, Giannoudis PV: Biological
enhancement of tibial diaphyseal aseptic non-unions: the efficacy of
autologous bone grafting, BMPs and reaming by-products. Injury 2007,
38(Suppl 2):S65-75.
30. Bodamyali T, Bhatt B, Hughes FJ, Winrow VR, Kanczler JM, Simon B,
Abbott J, Blake DR, Stevens CR: Pulsed electromagnetic fields
simultaneously induce osteogenesis and upregulate transcription of
bone morphogenetic proteins 2 and 4 in rat osteoblasts in vitro.
Biochem Biophys Res Commun 1998, 250:458-461.
31. Selvamurugan N, Kwok S, Vasilov A, Jefcoat SC, Partridge NC: Effects of
BMP-2 and pulsed electromagnetic field (PEMF) on rat primary
osteoblastic cell proliferation and gene expression. J Orthop Res 2007,
25:1213-1220.
32. Schwartz Z, Simon BJ, Duran MA, Barabino G, Chaudhri R, Boyan BD: Pulsed
electromagnetic fields enhance BMP-2 dependent osteoblastic
differentiation of human mesenchymal stem cells. J Orthop Res 2008.
33. Khosla S: Minireview: the OPG/RANKL/RANK system. Endocrinology 2001,
142:5050-5055.
34. Tanaka SM, Li J, Duncan RL, Yokota H, Burr DB, Turner CH: Effects of broad
frequency vibration on cultured osteoblasts. J Biomech 2003, 36:73-80.
35. Yang CM, Chien CS, Yao CC, Hsiao LD, Huang YC, Wu CB: Mechanical
strain induces collagenase-3 (MMP-13) expression in MC3T3-E1
osteoblastic cells. J Biol Chem 2004, 279:22158-22165.
36. Jansen JH, Jahr H, Verhaar JA, Pols HA, Chiba H, Weinans H, van
Leeuwen JP: Stretch-induced modulation of matrix metalloproteinases in
mineralizing osteoblasts via extracellular signal-regulated kinase-1/2. J
Orthop Res 2006, 24:1480-1488.
37. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT: Bone
morphogenetic proteins, extracellular matrix, and mitogen-activated
protein kinase signaling pathways are required for osteoblast-specific
gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res
2002, 17:101-110.
38. Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng SL: Erk
is essential for growth, differentiation, integrin expression, and cell
function in human osteoblastic cells. J Biol Chem 2001, 276:14443-14450.
39. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF:
Adult human mesenchymal stem cell differentiation to the osteogenic
or adipogenic lineage is regulated by mitogen-activated protein kinase.
J Biol Chem 2000, 275:9645-9652.
40. Peverali FA, Basdra EK, Papavassiliou AG: Stretch-mediated activation of
selective MAPK subtypes and potentiation of AP-1 binding in human
osteoblastic cells. Mol Med 2001, 7:68-78.
41. Rubin J, Murphy TC, Fan X, Goldschmidt M, Taylor WR: Activation of
extracellular signal-regulated kinase is involved in mechanical strain
inhibition of RANKL expression in bone stromal cells. J Bone Miner Res
2002, 17:1452-1460.
42. Farrell E, van der Jagt OP, Koevoet W, Kops N, van Manen CJ,
Hellingman CA, Jahr H, O’Brien FJ, Verhaar JA, Weinans H, van Osch GJ:
Chondrogenic priming of human bone marrow stromal cells: a better
route to bone repair? Tissue Eng Part C Methods 2009, 15:285-295.
43. Chiba H, Sawada N, Ono T, Ishii S, Mori M: Establishment and
characterization of a simian virus 40-immortalized osteoblastic cell line
from normal human bone. Jpn J Cancer Res 1993, 84:290-297.
44. Eijken M, Meijer IM, Westbroek I, Koedam M, Chiba H, Uitterlinden AG,
Pols HA, van Leeuwen JP: Wnt signaling acts and is regulated in a
human osteoblast differentiation dependent manner. J Cell Biochem
2008, 104:568-579.
45. Karsten U, Wollenberger A: Improvements in the ethidium bromide
method for direct fluorometric estimation of DNA and RNA in cell and
tissue homogenates. Anal Biochem 1977, 77:464-470.
46. Lowry OH, Roberts NR, Wu M-L, Hixon WS, Crawford EJ: The quantitative
histochemistry of brain. II enzyme measurements. J Biol Chem 1954,
207:19-27.
47. Jahr H, van Driel M, van Osch GJ, Weinans H, van Leeuwen JP:
Identification of acid-sensing ion channels in bone. Biochem Biophys Res
Commun 2005, 337:349-354.
48. Das RH, Jahr H, Verhaar JA, van der Linden JC, van Osch GJ, Weinans H: In
vitro expansion affects the response of chondrocytes to mechanical
stimulation. Osteoarthritis Cartilage 2008, 16:385-391.
Jansen et al. BMC Musculoskeletal Disorders 2010, 11:188
http://www.biomedcentral.com/1471-2474/11/188
Page 10 of 11
49. Mandl EW, Jahr H, Koevoet JL, van Leeuwen JP, Weinans H, Verhaar JA, van
Osch GJ: Fibroblast growth factor-2 in serum-free medium is a potent
mitogen and reduces dedifferentiation of human ear chondrocytes in
monolayer culture. Matrix Biol 2004, 23:231-241.
50. Stein GS, Lian JB, Owen TA: Relationship of cell growth to the regulation
of tissue-specific gene expression during osteoblast differentiation. Faseb
J 1990, 4:3111-3123.
51. Nikolova T, Czyz J, Rolletschek A, Blyszczuk P, Fuchs J, Jovtchev G,
Schuderer J, Kuster N, Wobus AM: Electromagnetic fields affect transcript
levels of apoptosis-related genes in embryonic stem cell-derived neural
progenitor cells. Faseb J 2005, 19:1686-1688.
52. Sollazzo V, Traina GC, DeMattei M, Pellati A, Pezzetti F, Caruso A: Responses
of human MG-63 osteosarcoma cell line and human osteoblast-like cells
to pulsed electromagnetic fields. Bioelectromagnetics 1997, 18:541-547.
53. Fitzsimmons RJ, Farley JR, Adey WR, Baylink DJ: Frequency dependence of
increased cell proliferation, in vitro, in exposures to a low-amplitude,
low-frequency electric field: evidence for dependence on increased
mitogen activity released into culture medium. J Cell Physiol 1989,
139:586-591.
54. Tepper OM, Callaghan MJ, Chang EI, Galiano RD, Bhatt KA, Baharestani S,
Gan J, Simon B, Hopper RA, Levine JP, Gurtner GC: Electromagnetic fields
increase in vitro and in vivo angiogenesis through endothelial release of
FGF-2. Faseb J 2004, 18:1231-1233.
55. Matsunaga S, Sakou T, Ijiri K: Osteogenesis by pulsing electromagnetic
fields (PEMFs): optimum stimulation setting. In Vivo 1996, 10:351-356.
56. Neidlinger-Wilke C, Stalla I, Claes L, Brand R, Hoellen I, Rubenacker S,
Arand M, Kinzl L: Human osteoblasts from younger normal and
osteoporotic donors show differences in proliferation and TGF beta-
release in response to cyclic strain. J Biomech 1995, 28:1411-1418.
57. Bostrom MP, Asnis P: Transforming growth factor beta in fracture repair.
Clin Orthop Relat Res 1998, S124-131.
58. Schmidmaier G, Schwabe P, Wildemann B, Haas NP: Use of bone
morphogenetic proteins for treatment of non-unions and future
perspectives. Injury 2007, 38(Suppl 4):S35-41.
59. Gruber R, Graninger W, Bobacz K, Watzek G, Erlacher L: BMP-6-induced
osteogenic differentiation of mesenchymal cell lines is not modulated
by sex steroids and resveratrol. Cytokine 2003, 23:133-137.
60. Ryoo HM, Lee MH, Kim YJ: Critical molecular switches involved in BMP-2-
induced osteogenic differentiation of mesenchymal cells. Gene 2006,
366:51-57.
61. Nagai M, Ota M: Pulsating electromagnetic field stimulates mRNA
expression of bone morphogenetic protein-2 and -4. J Dent Res 1994,
73:1601-1605.
62. Wang Z, Clark CC, Brighton CT: Up-regulation of bone morphogenetic
proteins in cultured murine bone cells with use of specific electric fields.
J Bone Joint Surg Am 2006, 88:1053-1065.
63. Heermeier K, Spanner M, Trager J, Gradinger R, Strauss PG, Kraus W,
Schmidt J: Effects of extremely low frequency electromagnetic field
(EMF) on collagen type I mRNA expression and extracellular matrix
synthesis of human osteoblastic cells. Bioelectromagnetics 1998,
19:222-231.
64. Eijken M, Swagemakers S, Koedam M, Steenbergen C, Derkx P,
Uitterlinden AG, van der Spek PJ, Visser JA, de Jong FH, Pols HA, van
Leeuwen JP: The activin A-follistatin system: potent regulator of human
extracellular matrix mineralization. Faseb J 2007, 21:2949-2960.
65. Jansen JH, Weyts FA, Westbroek I, Jahr H, Chiba H, Pols HA, Verhaar JA, van
Leeuwen JP, Weinans H: Stretch-induced phosphorylation of ERK1/2
depends on differentiation stage of osteoblasts. J Cell Biochem 2004,
93:542-551.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2474/11/188/prepub
doi:10.1186/1471-2474-11-188
Cite this article as: Jansen et al.: Stimulation of osteogenic
differentiation in human osteoprogenitor cells by pulsed
electromagnetic fields: an in vitro study. BMC Musculoskeletal Disorders
2010 11:188.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Jansen et al. BMC Musculoskeletal Disorders 2010, 11:188
http://www.biomedcentral.com/1471-2474/11/188
Page 11 of 11
